cilostazol has been researched along with ACA Infarct in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cilostazol (30 mg/kg) was intraperitoneally administered at 12 h before, 1 h before, and just after MCA occlusion." | 1.33 | Cilostazol reduces ischemic brain damage partly by inducing metallothionein-1 and -2. ( Hara, H; Hozumi, I; Inuzuka, T; Morimoto, N; Nagase, H; Shimazawa, M; Wakida, K, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wakida, K | 1 |
| Morimoto, N | 1 |
| Shimazawa, M | 1 |
| Hozumi, I | 1 |
| Nagase, H | 1 |
| Inuzuka, T | 1 |
| Hara, H | 1 |
1 other study available for cilostazol and ACA Infarct
| Article | Year |
|---|---|
Cilostazol reduces ischemic brain damage partly by inducing metallothionein-1 and -2.
Topics: Animals; Brain Ischemia; Cerebral Cortex; Cilostazol; Enzyme Induction; Immunohistochemistry; Infarc | 2006 |